Tuesday, October 10, 2006

Darth Doyle: $1 Million Tax Dollars for ESCR

Next time you send that quarterly "contribution" to the State of Wisconsin, remember this:

James Thomson and two others have started a second company that aims to grow platelets and red blood cells from embryonic stem cells.The company, called Stem Cell Products Inc., believes it has a chance to be among the first in the world to bring an embryonic stem cell-related therapeutic to market.

The path to a product will likely be less challenging because platelets and red blood cells contain no DNA, has limited lifespans in the body, and do not replicate, Thomson said at a news conference this morning.

Gov. Jim Doyle announced at the conference the state has awarded Stem Cell Products Inc. $1 million in technology development grants and loans.

The JSOnline article does not mention whether Thompson & Co. will be using "old" stem-cell lines or "new" ones.

I'm almost afraid to ask...

4 comments:

Anonymous said...

Guess this blows the wingnut theory about "no cures/treatments" from ESCR right out of the water, huh? And to think that the first cure/treatment will likely have a military application is just the icing on the cake.

Dad29 said...

"Red blood cells and platelets" are not "cures." Perhaps they will save lives--

But killing babies to save lives is, ah, perverse, at best.

Anonymous said...

Are you able to read, Daddy? What part of "cures/treatments" do you not understand? It may not be a cure, but it surely would be a treatment, and one of importance to the military.

On further reflection, you are right. The about-to-be-discarded fertilized eggs should NOT be used to save lifes or treat disease; they should be tossed in the nearest medical incinerator -- the fate which would otherwise befall them without the chance for ESCR.

I guess is was asking too much of a card-carrying wingnut to acknowledge that the "no cures/treatments" allegation was about to go by-by.

Anonymous said...

do you know if Stem Cell Products Inc. has a website?